In episode two of IntegriChain's 340B Series podcast, we're joined by Clay Willis, Partner of Advisory Services at IntegriChain. With years of hands-on experience guiding biopharma manufacturers and life sciences organizations through the 340B landscape, Clay unpacks key trends like duplicate discounts and the program's ongoing growth, along with practical strategies for managing and reducing 340B risk.
This episode dives into the 340B Rebate Model, how the industry got here, the latest developments, what the model does (and doesn't) solve for manufacturers, and what's on the horizon.